Sigurgeirsson B, Paul C, Curran D, Evans E G V
Department of Dermatology, University of Iceland and Landspitalinn, University Hospital, Reykjavik, Iceland.
Br J Dermatol. 2002 Dec;147(6):1241-3. doi: 10.1046/j.1365-2133.2002.05035.x.
There is considerable literature on the efficacy and safety of various drugs used in treating onychomycosis; however, little information is available regarding prognostic factors which may be associated with non-response to conventional treatment.
To identify parameters influencing mycological cure at 72 weeks following treatment of toenail onychomycosis with oral antifungal agents.
Univariate and multivariate logistic regression analysis from a randomized double-blind controlled trial including 496 patients with toenail onychomycosis caused by dermatophytes.
Baseline parameters including patient's age, gender, weight, number of toenails involved, percentage of nail involvement, duration of infection, history of previous treatment were not associated with mycological cure. In the multivariate prognostic factor analysis based on factors assessed at week 12, positive mycological culture at 12 weeks [odds ratio (OR): 0.583; 95% confidence interval (CI): 0.370-0.918] was negatively associated with mycological cure at 72 weeks. Similarly, in the multivariate prognostic factor analysis based on factors assessed at week 24, positive direct microscopy at 24 weeks (OR: 0.373; 95% CI: 0.211-0.659) and mycological culture at 24 weeks (OR: 0.293; 95% CI: 0.168-0.513) were negatively associated with mycological cure at 72 weeks.
Mycological culture at 12 and 24 weeks and direct microscopic examination at 24 weeks can help in early identification of patients failing to respond to conventional oral antifungal treatment.
关于用于治疗甲癣的各种药物的疗效和安全性,已有大量文献报道;然而,关于可能与对传统治疗无反应相关的预后因素的信息却很少。
确定口服抗真菌药物治疗趾甲甲癣72周后影响真菌学治愈的参数。
对一项随机双盲对照试验进行单因素和多因素逻辑回归分析,该试验纳入了496例由皮肤癣菌引起的趾甲甲癣患者。
包括患者年龄、性别、体重、受累趾甲数量、甲受累百分比、感染持续时间、既往治疗史等基线参数与真菌学治愈无关。在基于第12周评估因素的多因素预后因素分析中,第12周真菌培养阳性[比值比(OR):0.583;95%置信区间(CI):0.370 - 0.918]与72周时的真菌学治愈呈负相关。同样,在基于第24周评估因素的多因素预后因素分析中,第24周直接镜检阳性(OR:0.373;95% CI:0.211 - 0.659)和第24周真菌培养阳性(OR:0.293;95% CI:0.168 - 0.513)与72周时的真菌学治愈呈负相关。
第12周和第24周的真菌培养以及第24周的直接镜检有助于早期识别对传统口服抗真菌治疗无反应的患者。